MSP-RON signalling in cancer: pathogenesis and therapeutic potential (Q38116308)

29 August 2017

title

MSP-RON signalling in cancer: pathogenesis and therapeutic potential (English)

1 reference

29 August 2017

0 references

Hang-Ping Yao

1

1 reference

29 August 2017

Yong-Qing Zhou

series ordinal

2

1 reference

29 August 2017

Ruiwen Zhang

series ordinal

3

1 reference

29 August 2017

Ming-Hai Wang

series ordinal

4

1 reference

29 August 2017

language of work or name

English

0 references

publication date

1 July 2013

1 reference

29 August 2017

published in

Nature Reviews Cancer

1 reference

29 August 2017

volume

13

1 reference

29 August 2017

issue

7

1 reference

29 August 2017

page(s)

466-481

1 reference

Isolation of macrophage stimulating protein (MSP) from human serum

29 August 2017

cites work

1 reference

Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity

31 March 2020

1 reference

Characterization of the DNF15S2 locus on human chromosome 3: identification of a gene coding for four kringle domains with homology to hepatocyte growth factor

31 March 2020

1 reference

Characterization of the mouse cDNA and gene coding for a hepatocyte growth factor-like protein: expression during development

31 March 2020

1 reference

Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors

31 March 2020

1 reference

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

31 March 2020

1 reference

Feline STK gene expression in mammary carcinomas

31 March 2020

1 reference

Identification and developmental expression of a macrophage stimulating 1/ hepatocyte growth factor-like 1 orthologue in the zebrafish.

31 March 2020

1 reference

Macrophage-stimulating protein and calcium homeostasis in zebrafish.

31 March 2020

1 reference

Expression of HGF/SF, HGF1/MSP, and c-met suggests new functions during early chick development

31 March 2020

1 reference

Chicken macrophage stimulating protein is a ligand of the receptor protein-tyrosine kinase Sea.

31 March 2020

1 reference

Cloning and expression of Xenopus HGF-like protein (HLP) and Ron/HLP receptor implicate their involvement in early neural development

31 March 2020

1 reference

The putative transforming protein of S13 avian erythroblastosis virus is a transmembrane glycoprotein with an associated protein kinase activity.

31 March 2020

1 reference

The v-sea oncogene of avian erythroblastosis retrovirus S13: another member of the protein-tyrosine kinase gene family

31 March 2020

1 reference

Identification of the ron gene product as the receptor for the human macrophage stimulating protein

31 March 2020

1 reference

The murine stk gene product, a transmembrane protein tyrosine kinase, is a receptor for macrophage-stimulating protein

31 March 2020

1 reference

Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice

31 March 2020

1 reference

Restricted expression of the ron gene encoding the macrophage stimulating protein receptor during mouse development.

31 March 2020

1 reference

The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse

31 March 2020

1 reference

Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma.

31 March 2020

1 reference

Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease

31 March 2020

1 reference

Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells

31 March 2020

1 reference

The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.

31 March 2020

1 reference

Differential expression of RON in small and non-small cell lung cancers

31 March 2020

1 reference

Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target

31 March 2020

1 reference

Overexpression of the RON gene in human breast carcinoma

31 March 2020

1 reference

RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma

31 March 2020

1 reference

Expression and mutational status of RON in neoplastic lesions of the breast: analysis of MSP/RON signaling in ductal carcinoma in situ and invasive ductal carcinoma.

31 March 2020

1 reference

Involvement of recepteur d'origine nantais receptor tyrosine kinase in Epstein-Barr virus-associated nasopharyngeal carcinoma and its metastasis

31 March 2020

1 reference

A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype

31 March 2020

1 reference

Constitutive activation of the RON gene promotes invasive growth but not transformation

31 March 2020

1 reference

Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential

31 March 2020

1 reference

Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase

31 March 2020

1 reference

RON receptor tyrosine kinase in human gliomas: expression, function, and identification of a novel soluble splice variant

31 March 2020

1 reference

Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase

31 March 2020

1 reference

Altered exon usage in the juxtamembrane domain of mouse and human RON regulates receptor activity and signaling specificity

31 March 2020

1 reference

Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene

31 March 2020

1 reference

Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression

31 March 2020

1 reference

Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma

31 March 2020

1 reference

Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase

31 March 2020

1 reference

Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo

31 March 2020

1 reference

Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment

31 March 2020

1 reference

The Ron receptor promotes prostate tumor growth in the TRAMP mouse model.

31 March 2020

1 reference

The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells

31 March 2020

1 reference

Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines

31 March 2020

1 reference

Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers.

31 March 2020

1 reference

Ron tyrosine kinase receptor regulates papilloma growth and malignant conversion in a murine model of skin carcinogenesis.

31 March 2020

1 reference

Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation

31 March 2020

1 reference

The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans

31 March 2020

1 reference

The RON receptor tyrosine kinase promotes MSP-independent cell spreading and survival in breast epithelial cells

31 March 2020

1 reference

Hepatocyte growth factor activator is a serum activator of single-chain precursor macrophage-stimulating protein.

31 March 2020

1 reference

Proteolytic activation of pro-macrophage-stimulating protein by hepsin.

31 March 2020

1 reference

Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain

31 March 2020

1 reference

Interaction of macrophage-stimulating protein with its receptor. Residues critical for beta chain binding and evidence for independent alpha chain binding

31 March 2020

1 reference

The C terminus of RON tyrosine kinase plays an autoinhibitory role

31 March 2020

1 reference

Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein

31 March 2020

1 reference

The Crystal Structure of a Constitutively Active Mutant RON Kinase Suggests an Intramolecular Autophosphorylation Hypothesis

31 March 2020

1 reference

Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival

31 March 2020

1 reference

Characterization of cis-acting elements of the gene for macrophage-stimulating protein from the human. The involvement of positive and negative regulatory elements.

31 March 2020

1 reference

Hepatocyte nuclear factor-4 is responsible for the liver-specific expression of the gene coding for hepatocyte growth factor-like protein

31 March 2020

1 reference

Positive regulation of the human macrophage stimulating protein gene transcription. Identification of a new hepatocyte nuclear factor-4 (HNF-4) binding element and evidence that indicates direct association between NF-Y and HNF-4.

31 March 2020

1 reference

Proteolytic cleavage and activation of pro-macrophage-stimulating protein by resident peritoneal macrophage membrane proteases

31 March 2020

1 reference

Activation of macrophage-stimulating protein by human airway trypsin-like protease

31 March 2020

1 reference

Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway

31 March 2020

1 reference

Structure of the promoter for the human macrophage stimulating protein receptor gene

31 March 2020

1 reference

Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells

31 March 2020

1 reference

Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells

31 March 2020

1 reference

Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells

31 March 2020

1 reference

Novel Function of Transcription Factor Nrf2 as an Inhibitor of RON Tyrosine Kinase Receptor-mediated Cancer Cell Invasion

31 March 2020

1 reference

Upregulation of recepteur d'origine nantais tyrosine kinase and cell invasiveness via early growth response‐1 in gastric cancer cells

31 March 2020

1 reference

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter

31 March 2020

1 reference

Blocking tumorigenic activities of colorectal cancer cells by a splicing RON receptor variant defective in the tyrosine kinase domain

31 March 2020

1 reference

The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation

31 March 2020

1 reference

Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives

31 March 2020

1 reference

Crystal Structure of the Sema-PSI Extracellular Domain of Human RON Receptor Tyrosine Kinase

31 March 2020

1 reference

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

31 March 2020

1 reference

Requirement of both tyrosine residues 1330 and 1337 in the C-terminal tail of the RON receptor tyrosine kinase for epithelial cell scattering and migration

31 March 2020

1 reference

Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor

31 March 2020

1 reference

Distinct involvement of the Gab1 and Grb2 adaptor proteins in signal transduction by the related receptor tyrosine kinases RON and MET.

31 March 2020

1 reference

Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway

31 March 2020

1 reference

MSP-induced RON activation upregulates uPAR expression and cell invasiveness via MAPK, AP-1 and NF- B signals in gastric cancer cells

31 March 2020

1 reference

Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells

31 March 2020

1 reference

The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration

31 March 2020

2 references

31 March 2020

12 December 2020

Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes.

1 reference

Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.

31 March 2020

1 reference

The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome

31 March 2020

1 reference

Macrophage-stimulating protein activates Ras by both activation and translocation of SOS nucleotide exchange factor

31 March 2020

1 reference

Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity

31 March 2020

1 reference

Met, metastasis, motility and more

31 March 2020

1 reference

Mechanisms of cytoplasmic {beta}-catenin accumulation and its involvement in tumorigenic activities mediated by oncogenic splicing variant of the receptor originated from Nantes tyrosine kinase

31 March 2020

1 reference

Integrin-mediated RON growth factor receptor phosphorylation requires tyrosine kinase activity of both the receptor and c-Src

31 March 2020

1 reference

c-Cbl is a critical modulator of the Ron tyrosine kinase receptor

31 March 2020

1 reference

Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling.

31 March 2020

1 reference

Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor.

31 March 2020

1 reference

Ribosomal Protein S6 Kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein

31 March 2020

1 reference

RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells

31 March 2020

1 reference

A genome-wide RNAi screen identifies multiple RSK-dependent regulators of cell migration

31 March 2020

1 reference

Myeloid-specific expression of Ron receptor kinase promotes prostate tumor growth.

31 March 2020

1 reference

Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase

31 March 2020

1 reference

Cross-talk between the proto-oncogenes Met and Ron

31 March 2020

1 reference

Ron kinase transphosphorylation sustains MET oncogene addiction

31 March 2020

1 reference

Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor

31 March 2020

1 reference

Collaboration of RON and epidermal growth factor receptor in human bladder carcinogenesis.

31 March 2020

1 reference

An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells

31 March 2020

1 reference

Transactivation of RON receptor tyrosine kinase by interaction with PDGF receptor beta during steady-state growth of human mesangial cells.

31 March 2020

1 reference

Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas

31 March 2020

1 reference

IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration

31 March 2020

1 reference

Fv2 encodes a truncated form of the Stk receptor tyrosine kinase

31 March 2020

1 reference

The envelope glycoprotein of friend spleen focus-forming virus covalently interacts with and constitutively activates a truncated form of the receptor tyrosine kinase Stk.

31 March 2020

1 reference

Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus

31 March 2020

1 reference

Association of RON tyrosine kinase with the Jaagsiekte sheep retrovirus envelope glycoprotein

31 March 2020

1 reference

Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus–mediated B-cell proliferation

31 March 2020

1 reference

β-Catenin is required for Ron receptor-induced mammary tumorigenesis

31 March 2020

1 reference

Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.

31 March 2020

1 reference

Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer

31 March 2020

1 reference

Activation of the N-terminally truncated form of the Stk receptor tyrosine kinase Sf-Stk by Friend virus-encoded gp55 is mediated by cysteine residues in the ecotropic domain of gp55 and the extracellular domain of Sf-Stk

31 March 2020

1 reference

RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectal carcinoma cells

31 March 2020

1 reference

Sensitivity of selected human tumor models to PF-04217903, a novel selective c-Met kinase inhibitor

31 March 2020

1 reference

Oncogenic variant RON160 expression in breast cancer and its potential as a therapeutic target by small molecule tyrosine kinase inhibitor

31 March 2020

1 reference

Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo

31 March 2020

1 reference

Discovery of N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the Met kinase superfamily

31 March 2020

1 reference

Small-molecule inhibitor BMS-777607 induces breast cancer cell polyploidy with increased resistance to cytotoxic chemotherapy agents

31 March 2020

1 reference

Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member

31 March 2020

1 reference

The monoclonal antibody Zt/f2 targeting RON receptor tyrosine kinase as potential therapeutics against tumor growth-mediated by colon cancer cells

31 March 2020

1 reference

Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.

31 March 2020

1 reference

Co-expression of RON and MET is a prognostic indicator for patients with transitional-cell carcinoma of the bladder

31 March 2020

1 reference

Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract

31 March 2020

1 reference

The prognostic significance of RON and MET receptor coexpression in patients with colorectal cancer

31 March 2020

1 reference

Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients.

31 March 2020

1 reference

Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues

31 March 2020

1 reference

RON is not a prognostic marker for resectable pancreatic cancer

31 March 2020

1 reference

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

31 March 2020

1 reference

Expression and mutational analysis of MET in human solid cancers

31 March 2020

1 reference

Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma.

31 March 2020

1 reference

Expression of the receptor tyrosine kinase recepteur d'origine nantais and its association with tumor progression in hypopharyngeal cancer

31 March 2020

1 reference

Isolation of Fully Human Antagonistic RON Antibodies Showing Efficient Block of Downstream Signaling and Cell Migration.

31 March 2020

1 reference

RON receptor tyrosine kinase as a target for delivery of chemodrugs by antibody directed pathway for cancer cell cytotoxicity

31 March 2020

1 reference

Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase

31 March 2020

1 reference

Sustained expression of the RON receptor tyrosine kinase by pancreatic cancer stem cells as a potential targeting moiety for antibody-directed chemotherapeutics

31 March 2020

1 reference

Antibody-drug conjugates in cancer therapy

31 March 2020

1 reference

Trastuzumab emtansine for HER2-positive advanced breast cancer

31 March 2020

1 reference

Brentuximab Vedotin (SGN-35)

31 March 2020

1 reference

Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma

31 March 2020

1 reference

Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells

31 March 2020

1 reference

A novel Stat3 binding motif in Gab2 mediates transformation of primary hematopoietic cells by the Stk/Ron receptor tyrosine kinase in response to Friend virus infection

31 March 2020

1 reference

Role of phosphatidylinositol 3-kinase in friend spleen focus-forming virus-induced erythroid disease

31 March 2020

1 reference

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

31 March 2020

1 reference

Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases

31 March 2020

1 reference

A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2.

31 March 2020

1 reference

Targeting the Met pathway in lung cancer

31 March 2020

1 reference

Discovery of a 5H-Benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer

31 March 2020

1 reference

MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor

31 March 2020

1 reference

Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met

31 March 2020

1 reference

RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP

31 March 2020

1 reference

12 December 2020

Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.

1 reference

12 December 2020

Identification of a novel splicing product of the RON receptor tyrosine kinase in human colorectal carcinoma cells

1 reference

12 December 2020

Alterations in a defined extracellular region of the RON receptor tyrosine kinase promote RON-mediated motile and invasive phenotypes in epithelial cells.

1 reference

12 December 2020

Requirement of phosphatidylinositol-3 kinase for epithelial cell migration activated by human macrophage stimulating protein

1 reference

12 December 2020

Monoclonal antibody (mAb)-induced down-regulation of RON receptor tyrosine kinase diminishes tumorigenic activities of colon cancer cells.

1 reference

12 December 2020

Cloning, sequencing, and expression of human macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the family of kringle proteins and locates the MSP gene on chromosome 3

1 reference

12 December 2020

Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.

1 reference

12 December 2020

Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples

1 reference

12 December 2020

The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors.

1 reference

12 December 2020

Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells.

1 reference

12 December 2020

STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family

1 reference

12 December 2020

The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues.

1 reference

12 December 2020

Enhancement of Spreading, Phagocytosis and Chemotaxis by Macrophage Stimulating Protein (MSP)

1 reference

12 December 2020

Expression of hepatocyte growth factor-like protein is repressed by retinoic acid and enhanced by cyclic adenosine 3',5'-monophosphate response element-binding protein (CREB)-binding protein (CBP).

1 reference

12 December 2020

Proteolytic activation of single-chain precursor macrophage-stimulating protein by nerve growth factor-gamma and epidermal growth factor-binding protein, members of the kallikrein family

1 reference

12 December 2020

A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo

1 reference

12 December 2020

A novel putative receptor protein tyrosine kinase of the met family

1 reference

12 December 2020

Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets

1 reference

12 December 2020

Proteolytic conversion of single chain precursor macrophage-stimulating protein to a biologically active heterodimer by contact enzymes of the coagulation cascade

1 reference

12 December 2020

Expression and maturation of the cellular sea receptor, a member of the hepatocyte growth factor (HGF) receptor family of protein tyrosine kinases.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3545

1 reference

Dimensions Publication ID

29 August 2017

1047819397

0 references

1 reference